Ace Blend Raises $9.9 Mn To Fund Clinical Trials, Expand Nutrition Portfolio
Led by 3one4 Capital with participation from Fireside Ventures, the funding will support R&D, supply chain upgrades, and scientific testing. The company aims to use peer-reviewed journals and automated testing to validate its health claims.
Key points
- Raised $9.9 million in Series A2 round
- Funds allocated for clinical trials and R&D
- Focus on scientific evidence for nutritional supplements
Summary and key points written by AI from the headline and a short excerpt, so they can be incomplete or wrong. Inc42 did the reporting; read the original for the full story.
Read the full story at Inc42
